JP Morgan initiated coverage on Sapiens Int'l with a new price target
$SPNS
Computer Software: Prepackaged Software
Technology
JP Morgan initiated coverage of Sapiens Int'l with a rating of Underweight and set a new price target of $20.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2023 | $24.00 | Equal Weight → Underweight | Barclays |
| 1/23/2023 | $28.00 | Buy | Goldman |
| 12/1/2022 | $20.00 | Underweight | JP Morgan |
| 2/24/2022 | $38.00 → $30.00 | Buy | Citigroup |
| 2/24/2022 | $40.00 → $36.00 | Buy | Needham |
| 12/14/2021 | Neutral → Underweight | JP Morgan | |
| 12/14/2021 | $35.00 | Neutral → Underweight | JP Morgan |
| 7/13/2021 | $35.00 | Overweight → Neutral | JP Morgan |
Barclays downgraded Sapiens Int'l from Equal Weight to Underweight and set a new price target of $24.00
Goldman initiated coverage of Sapiens Int'l with a rating of Buy and set a new price target of $28.00
JP Morgan initiated coverage of Sapiens Int'l with a rating of Underweight and set a new price target of $20.00
6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)
6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)
6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)
HOLON, Israel, April 26, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the appointment of Jamie Yoder as President and General Manager of Sapiens North America. Mr. Yoder's depth of leadership experience in the insurance and technology sectors, including senior management positions at top global professional services firms (such as PwC), will further strengthen Sapiens' footprint, strategy, and operations in North America and globally. Sapiens will benefit from his strong acumen across various touchpoints within the insurance life cycle, especially in these times
Needham analyst Mayank Tandon reiterates Sapiens Intl Corp (NASDAQ:SPNS) with a Buy and maintains $38 price target.
ROCHELLE PARK, N.J., Nov. 11, 2024 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2024. Summary Results for Third Quarter 2024 (USD in millions, except per share data) GAAP Non-GAAP Q3 2024 Q3 2023 % Change Q3 2024 Q3 2023 % Change Revenue $137.0 $130.7 4.8 % $137.0 $130.8 4.8 % Gross Profit $60.3 $56.0 7.8 % $62.8 $59.3 6.0 % Gross Margin 44.0 % 42.8 % 120 bps 45.8 % 45.3 % 50 bps Operating Income $21.7 $20.3 7.3 % $25.1 $24.1 4.3 % Operating Margin 15.9 % 15.5 % 40 bps 18.3 % 18.4 % -10 bps Net Inco
ROCHELLE PARK, N.J., Oct. 28, 2024 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Third quarter of 2024 on Monday, November 11, 2024. Management will host a conference call and webcast on November 11, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): 1-888-642-5032 International: 972-3-9180644 UK: 0-800-917-5108 The live webcast of the call can be acces
ROCHELLE PARK, N.J., Aug. 15, 2024 /PRNewswire/ -- Sapiens International Corporation N.V. (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that its board of directors has approved the distribution of a cash dividend of $0.29 per share, or $16.2 million in total, based on 2024 first half results. The dividend is in line with the company's policy of distributing on a semi-annual basis up to 40% of its annual non-GAAP net income and will be paid on September 12, 2024, to Sapiens' shareholders of record, as of August 28, 2024. The dividend is subject to withholding of Israeli tax at source at the rate of 25% of the dividend a
SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)
SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)
SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)
ROCHELLE PARK, N.J., Nov. 11, 2024 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2024. Summary Results for Third Quarter 2024 (USD in millions, except per share data) GAAP Non-GAAP Q3 2024 Q3 2023 % Change Q3 2024 Q3 2023 % Change Revenue $137.0 $130.7 4.8 % $137.0 $130.8 4.8 % Gross Profit $60.3 $56.0 7.8 % $62.8 $59.3 6.0 % Gross Margin 44.0 % 42.8 % 120 bps 45.8 % 45.3 % 50 bps Operating Income $21.7 $20.3 7.3 % $25.1 $24.1 4.3 % Operating Margin 15.9 % 15.5 % 40 bps 18.3 % 18.4 % -10 bps Net Inco
Sapiens DataSuite on the cloud accelerates the insurer's scalability and cost-efficiency, streamlines operations, and enables faster insights UXBRIDGE, England, Nov. 4, 2024 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the go-live of Sapiens DataSuite by a Tier 1 insurer based in Africa. Powered by Sapiens DataSuite, the migration of the insurer's data platform to the cloud provides the company with an enterprise-wide, consolidated view of data to improve performance, productivity, security, and user experiences. A longtime Sapiens' customer, the insurer implemented S
ROCHELLE PARK, N.J., Oct. 28, 2024 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the Third quarter of 2024 on Monday, November 11, 2024. Management will host a conference call and webcast on November 11, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): 1-888-642-5032 International: 972-3-9180644 UK: 0-800-917-5108 The live webcast of the call can be acces